Staffan Holmberg-Thyden (Staffan Holmberg-Thydén)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Risk Assessment

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Cancer immunology, immunotherapy : CII

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Casey L O'Connell, Maria R Baer, Andreas Due Ørskov, Sunil Kumar Saini, Vu H Duong, Patricia Kropf, Jakob Werner Hansen, Denice Tsao-Wei, Hyo Sik Jang, Ashkan Emadi, Staffan Holmberg-Thyden, Jack Bernard Cowland, Brett T Brinker, Kristin Horwood, Ryan S Burgos, Galen Hostetter, Benjamin A Youngblood, Sine Reker Hadrup, Jean-Pierre J Issa, Peter A Jones, Stephen B Baylin, Imran Siddiqi, Kirsten Grønbaek
Safety, outcomes and T cell characteristics in patients with relapsed or refractory MDS or CMML treated with atezolizumab in combination with guadecitabine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sunil Kumar Saini, Staffan Holmberg-Thyden, Anne-Mette Bjerregaard, Ashwin Unnikrishnan, Simon Dorfmüller, Uwe Platzbecker, Irene Tirado-Gonzalez, Halvard Bönig, Daniel El Fassi, Kirsten Grønbæk, John E Pimanda, Hind Medyouf, Sine Reker Hadrup
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies. Leukemia 36 (11) (2022)
Staffan Holmberg-Thyden, Inge Høgh Dufva, Anne Ortved Gang, Marie Fredslund Breinholt, Lone Schejbel, Mette Klarskov Andersen, Mohammad Kadivar, Inge Marie Svane, Kirsten Grønbæk, Sine Reker Hadrup, Daniel El Fassi
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial. Cancer immunology, immunotherapy : CII (2021)
Sunil Kumar Saini, Andreas Due Ørskov, Anne-Mette Bjerregaard, Ashwin Unnikrishnan, Staffan Holmberg-Thyden, Annie Borch, Kathrine Valentini Jensen, Govardhan Anande, Amalie Kai Bentzen, Andrea Marion Marquard, Tripti Tamhane, Marianne Bach Treppendahl, Anne Ortved Gang, Inge Høgh Dufva, Zoltan Szallasi, Nicola Ternette, Anders Gorm Pedersen, Aron Charles Eklund, John E Pimanda, Kirsten Grønbæk, Sine Reker Hadrup
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers. Nature communications 11 (1) (2020)